Supernus Pharmaceuticals to Announce First Quarter 2026 Financial Results and Host Conference Call on May 5, 2026
Supernus Pharmaceuticals announced it will report first quarter 2026 financial results after the market closes on May 5, 2026. President and CEO Jack Khattar and SVP and CFO Tim Dec will host a conference call and webcast at 4:30 p.m. ET on the same day to discuss the results.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.